cadth 2015 c2 panel.mohsen

15
How to integrate external evidence into within trial economic evaluations? Mohsen Sadatsafavi MD, PhD University of British Columbia 2015.04.13

Upload: cadth-symposium

Post on 14-Aug-2015

33 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Cadth 2015 c2 panel.mohsen

How to integrate external evidence into within trial economic evaluations?

Mohsen Sadatsafavi MD, PhDUniversity of British Columbia

2015.04.13

Page 2: Cadth 2015 c2 panel.mohsen

2

Conflict of Interest

No apparent or perceived conflict of interest

Received CIHR fellow-ship award for this work

All interpretations are my own

Our TeamCarlo Marra, Shawn Aaron, Stirling Bryan

Page 3: Cadth 2015 c2 panel.mohsen

3

Outline

• A novel method for incorporating external evidence in economic evaluations

• Context in which it is applicable• What it does• A running example• Pros + Cons + conclusions

Page 4: Cadth 2015 c2 panel.mohsen

4

Economic trialsas vehicles for evaluations

• Model-based evaluations• Evidence is ‘parameterized’ and fed into a computer

program (mathematical function)

• simulation

• Trial-based evaluations• Individuals are assigned to competing treatments and

their experiences is represented through cost and effectiveness values

• (bivariate) statistical inference• bootstrap as s popular paradigm

Page 5: Cadth 2015 c2 panel.mohsen

5

Issues with trial-based CEAs

Failure to compare all available options

A truncated time horizon

Lack of relevance to the jurisdiction of interest

Failure to incorporate all evidence the most damning criticism

Page 6: Cadth 2015 c2 panel.mohsen

6

ContextAn example: OPTIMAL trial in COPD

• Mono, double, and triple inhaler therapy in COPD (T1, T2, T3)

• N=442• Follow-up 1 year• Primary outcome: exacerbation rate• Prospective economic evaluation component• Results

– RR of T2 v. T1: 1.01 (0.59 – 0.73)– RR of T3 v. T1: 0.84 (0.47 – 1.49)

Page 7: Cadth 2015 c2 panel.mohsen

7

ContextOPTIMAL CEA

• Sequence of imputation, regression, outcome calculations within a bootstrap envelope

Page 8: Cadth 2015 c2 panel.mohsen

8

Trialist versus economist

Treatment effects (RR=0.84, NS) ICER=243K

Pooled estimate

Regression-based methods Bootstrap methods

OPTIMAL trial

Trialist Economist

Decision maker

Welte et. al. T3 v. T1

RR=0.38 (0.28 – 0.57)

Meta-analyst

Page 9: Cadth 2015 c2 panel.mohsen

9

CONTEXTReconciling external evidence in RCT-based CEAs

Desist RCT-based CEA and resort to model-based evaluation Paradigm shift

Switch to parametric Bayesian evidence synthesisMCMC using WinBUGS (technical, lots of programing, model

convergence etc) Off-putting

Stay with the bootstrap-based methods, incorporate external evidence

Page 10: Cadth 2015 c2 panel.mohsen

10

MethodsRCT-CEA without external evidence

Page 11: Cadth 2015 c2 panel.mohsen

11

MethodsRCT-CEA with external evidence

Page 12: Cadth 2015 c2 panel.mohsen

12

ResultsCase study in COPD

Page 13: Cadth 2015 c2 panel.mohsen

13

ResultsCase study in COPD

Page 14: Cadth 2015 c2 panel.mohsen

14

Conclusions

• Theoretically, possible to use trials as ‘vehicle’ for evidence synthesis, yet avoid the ‘most damning criticism’

• Practically, with too many parameters, it can be computationally prohibitive

• Best use is in sensitivity and secondary analyses• What if we incorporate the results of the study by xyz?

• The experts in our team believe it is almost impossible that chemo+radiation increases the risk of metastasis ->half-flat priors

Page 15: Cadth 2015 c2 panel.mohsen

FacultyMohsen SadatsafaviJ Mark FitzGeraldStirling BryanLarry Lynd

Research StaffHamid TavakoliTania ConteRoxanne Rousseau

StudentsZafar ZafariWenjia Chen

Thank You!

[email protected]

Respiratory Evaluation Sciences Program (resp.med.ubc.ca)